Crossing the Digital Divide – MedCity News

[ad_1] We’re all familiar with the stories of Blockbuster Video, Radio Shack, and Kodak—business school case studies on failing to anticipate future market needs—but are we effectively preparing our own…

Jenny Craig is going out of business | CNN Business

[ad_1] New York CNN  —  Jenny Craig, the weight-loss chain, has confirmed that it’s shutting down for good. “It’s with a heavy heart, we’re announcing the close of our business,”…

Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand Surges

[ad_1] Lower-strength starter doses of the obesity drug will be held back in the U.S. to safeguard supplies, said pharmaceutical company Novo Nordisk. [ad_2] Source link

Switzerland Diabetes Market, Size, Forecast 2023-2028 |

[ad_1] According to Renub Research latest report, “Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis” the Switzerland Diabetes Market is…

Obesity Drug Hype Outweighs Profit Miss at Eli Lilly

[ad_1] Mounjaro excitement more than makes up for company’s first quarter results. [ad_2] Source link

Powerful New Obesity Drug Poised to Upend Weight Loss Care

[ad_1] As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity…

The fight against Type 1 diabetes has begun – ADO – Ghana Business News

[ad_1] The Ark Development Organisation (ADO), a not for profit organisation, in collaboration with the Eastern Regional Health Directorate, Ghana Health Service, is working towards ensuring good…

Big drug company CEOs to testify at Senate Health committee on insulin prices

[ad_1] In this photo illustration, an insulin pen manufactured by the Novo Nordisk company is displayed on March 14, 2023 in Miami, Florida. Joe Raedle | Getty Images News |…

Elevance Health Earnings Rise With Uptick in Premiums, Enrollment

[ad_1] The health insurer’s operating revenue in the first quarter was lifted by membership growth in Medicaid and Medicare Advantage. [ad_2] Source link

Demand for Obesity Drugs Has Insurers Paying Close Attention

[ad_1] Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results [ad_2] Source link